Sign in
4

Changes in Ownership

Adaptive Biotechnologies Corp Filed Acc 0001209191-19-062022

President sold 160,000 shares at an average $29.73 ($4,757,060)

  • President acquired 160,000 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
RUBINSTEIN JULIE President 2019-12-24 Option exercise +25,000 $0.33 $8,250 25,000 D: show line 1 in the form
RUBINSTEIN JULIE President 2019-12-24 Option exercise +55,000 $0.33 $18,150 80,000 D: show line 2 in the form
RUBINSTEIN JULIE President 2019-12-24 Sale −79,500 $30.09 $2,392,155 500 D: show line 3 in the form
RUBINSTEIN JULIE President 2019-12-24 Sale −500 $30.61 $15,305 0 D: show line 4 in the form
RUBINSTEIN JULIE President 2019-12-26 Option exercise +45,000 $0.33 $14,850 45,000 D: show line 5 in the form
RUBINSTEIN JULIE President 2019-12-26 Option exercise +35,000 $0.45 $15,750 80,000 D: show line 6 in the form
RUBINSTEIN JULIE President 2019-12-26 Sale −80,000 $29.37 $2,349,600 0 D: show line 7 in the form
Open-market sales · 160,000 sh · avg $29.73 · $4,757,060

Table II: Derivative

Insider Date Transaction Shares Price Value Owned after D/I
RUBINSTEIN JULIE President 2019-12-24 Option exercise · Stock Option (Right to Buy) −25,000 0 D: show line 8 in the form
RUBINSTEIN JULIE President 2019-12-24 Option exercise · Stock Option (Right to Buy) −55,000 45,000 D: show line 9 in the form
RUBINSTEIN JULIE President 2019-12-26 Option exercise · Stock Option (Right to Buy) −45,000 0 D: show line 10 in the form
RUBINSTEIN JULIE President 2019-12-26 Option exercise · Stock Option (Right to Buy) −35,000 35,000 D: show line 11 in the form
Loading xslF345X03/doc4.xml…